Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:24 Issue:1 Number:2 ISSN#:2564-2537
Author Verified
RCT
ACE Report #13494
Ace Report Cover Peri-Operative

IV TXA Reduces Blood Loss & Transfusion Rate in Hip Fracture Surgery


How to Cite

OrthoEvidence. IV TXA Reduces Blood Loss & Transfusion Rate in Hip Fracture Surgery. ACE Report. 2021;24(1):2. Available from: https://myorthoevidence.com/AceReport/Report/13494

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial

Bone Joint J. 2021 Mar;103-B(3): 442-448.

Contributing Authors: VS Nikolaou P Masouros T Floros E Chronopoulos M Skertsou GC Babis

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and sixty-five elderly patients scheduled to receive a cemented hemiarthroplasty for a subcapital hip fracture (n=64) or intramedullary nailing procedure for intertrochanteric fracture (n=101) were randomized to receive intravenous tranexamic acid (TXA; n=77) or a normal saline placebo (n=88) for the reduction of blood loss and transfusion rates. Outcomes of interest included total blo...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.